US2021189073A1PendingUtilityA1

Curable composition

Assignee: DAIKIN IND LTDPriority: Oct 31, 2017Filed: Oct 30, 2018Published: Jun 24, 2021
Est. expiryOct 31, 2037(~11.3 yrs left)· nominal 20-yr term from priority
Inventors:Yoshiaki Honda
C08L 71/02C08G 77/045C08G 77/12C08G 77/24C08L 83/08C08L 83/04C08G 65/007C08G 65/336C08G 77/46C08K 5/5419C08L 71/00C08G 77/08
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A curable composition including (A) a compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule, wherein the perfluoro(poly)ether group is represented by formula: —(OC6F12)a—(OC5F10)b—(OC4F8)c—(OC3X106)d—(OC2F4)e—(OCF2)f—, wherein a, b, c and d are each independently an integer of 0 to 30, e and f are each independently an integer of 1 to 200, the sum of a, b, c, d, e and f is at least 5 or more, the occurrence order of the respective repeating units in parentheses with the subscript a, b, c, d, e or f is not limited in the formula, a ratio of e to f is less than 1.0, and each X10, at each occurrence, is independently a hydrogen atom, a fluorine atom or a chlorine atom, (B) an organosilicon compound which has two or more hydrogen atoms each bonding to a silicon atom, in one molecule, and (C) a catalyst.

Claims

exact text as granted — not AI-modified
1 . A curable composition comprising:
 (A) a compound which is a compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule, wherein   the perfluoro(poly)ether group is a group represented by formula:
   —(OC 6 F 12 ) a —(OC 5 F 10 ) b —(OC 4 F 8 ) c —(OC 3 X 10   6 ) d —(OC 2 F 4 ) e —(OCF 2 ) f —
 
   wherein a, b, c and d are each independently an integer of 0 or more and 30 or less, e and f are each independently an integer of 1 or more and 200 or less, the sum of a, b, c, d, e and f is at least 5 or more, the occurrence order of the respective repeating units in parentheses with the subscript a, b, c, d, e or f is not limited in the formula, a ratio of e to f is less than 1.0, and each X 10 , at each occurrence, is independently a hydrogen atom, a fluorine atom or a chlorine atom;   (B) an organosilicon compound which has two or more hydrogen atoms each bonding to a silicon atom, in one molecule; and   (C) a catalyst.   
     
     
         2 . The curable composition according to  claim 1 , wherein
 (A) the compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule is a compound represented by formula (I):
   CH 2 ═CH—R k1 -PFPE 1 -R k1 —CH═CH 2   (I)
 
   wherein:   each R k1 , at each occurrence, independently represents a single bond or a divalent organic group; and   each PFPE 1 , at each occurrence, independently represents
   —(OC 6 F 12 ) a —(OC 5 F 10 ) b —(OC 4 F 8 ) c —(OC 3 X 10   6 ) d —(OC 2 F 4 ) e —(OCF 2 ) f —
 
   wherein a, b, c and d are each independently an integer of 0 or more and 30 or less, e and f are each independently an integer of 1 or more and 200 or less, the sum of a, b, c, d, e and f is at least 5 or more, the occurrence order of the respective repeating units in parentheses with the subscript a, b, c, d, e or f is not limited in the formula, a ratio of e to f is less than 1.0, and each X 10 , at each occurrence, is independently a hydrogen atom, a fluorine atom or a chlorine atom.   
     
     
         3 . The curable composition according to  claim 1 , wherein a hydrogen atom bonding to a silicon atom in (B) the organosilicon compound which has two or more hydrogen atoms each bonding to a silicon atom, in one molecule, is comprised in the range from 0.5 to 5.0 mol based on 1 mol of an alkenyl group in (A) the compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule. 
     
     
         4 . The curable composition according to  claim 1 , wherein (B) the organosilicon compound which has two or more hydrogen atoms each bonding to a silicon atom, in one molecule, has at least one selected from the group consisting of one or more monovalent perfluoroalkyl groups, monovalent perfluorooxyalkyl groups, divalent perfluoroalkylene groups and divalent perfluorooxyalkylene groups, in a molecular structure. 
     
     
         5 . The curable composition according to  claim 1 , wherein the catalyst is a transition metal catalyst. 
     
     
         6 . The curable composition according to  claim 1 , wherein the catalyst comprises at least one comprising platinum, rhodium, ruthenium, iridium and palladium. 
     
     
         7 . The curable composition according to  claim 1 , wherein the catalyst comprises platinum. 
     
     
         8 . The curable composition according to  claim 1 , comprising 0.1 to 500 ppm by mass of the catalyst in terms of metal atom relative to (A) the compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule. 
     
     
         9 . The curable composition according to  claim 1 , wherein a ratio of the sum of e and f to the sum of a, b, c, d, e and f is 0.80 or more in (A) the compound having two or more alkenyl groups and a perfluoro(poly)ether group in one molecule. 
     
     
         10 . The curable composition according to  claim 1 , wherein X 10  is a fluorine atom.

Join the waitlist — get patent alerts

Track US2021189073A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.